There is a category of corporate announcement where the company is not just reacting to government policy. Rather, it is actively trying to shape it in a direction that happens to align precisely with its own long-term business model. Rocket Doctor AI’s (CSE: AIDR) (OTCQB: AIRDF) decision to have its subsidiary Rocket Doctor Inc. join the Alliance for Connected Care’s Telehealth Voters Pledge, with Co-Founder and COO Harry Cherniak traveling to Washington, D.C. this week to present the pledge directly to Members of Congress, is exactly that kind of move. It is worth understanding not just as a policy statement, but as a signal of where the company sees its future.
The Advocacy
The substance of the pledge is straightforward. Temporary Medicare telehealth provisions have been extended repeatedly rather than made permanent, creating recurring uncertainty for patients, physicians, and the healthcare organizations that serve them. Every time an extension approaches expiration, providers face the prospect of losing reimbursement for virtual care overnight. The coalition Rocket Doctor has joined, comprised of more than 130 organizations spanning national associations, health systems, rural health groups, and major industry players, is pushing Congress to replace that cycle of short-term renewals with permanent legislation.
Having a company co-founder present that pledge in person to lawmakers is a meaningful access signal in its own right. It places Rocket Doctor alongside more established health systems and national industry associations as a credible voice in the policy conversation, rather than as a peripheral observer of decisions made elsewhere. For a company still building out its market position, that kind of direct proximity to the people writing the rules is not something every competitor gets to claim.
But the more important dimension is how directly this advocacy overlaps with the communities Rocket Doctor has built its business around serving. The company has been explicit that its mission centers on reaching seniors, rural communities, underserved populations, and patients managing chronic conditions. These are the exact populations for whom Medicare telehealth access is not a convenience but often the only realistic way to see a physician regularly.
The Business
In the U.S., Rocket Doctor is now in-network with payers representing approximately 21 million covered lives, enabling eligible patients in California, New York, and Maryland to access physicians on its platform through Medicare, Medicaid, Veterans Affairs, and commercial insurance. That is not a small number, and it is a meaningful jump from the roughly 13 million lives the company had reported reaching as of Q3 2025. This is a detail disclosed almost in passing within this policy announcement, but one that matters considerably to anyone tracking the company’s underlying commercial trajectory.
Seen through that lens, the advocacy push is an extension of Rocket Doctor’s core business. A company whose growth strategy depends on Medicare-eligible patients being able to access physicians virtually has an obvious and direct interest in Congress removing the uncertainty that currently surrounds that access. Dr. William Cherniak, Co-Founder and CEO of Rocket Doctor Inc., made that connection explicit: “Permanent Medicare telehealth policy would provide the stability patients, physicians, and healthcare organizations need to continue investing in innovative models of care.” That is a business argument as much as a healthcare access argument, and it is worth reading it as both.
The Upshot
None of this guarantees an outcome. Congress has extended Medicare telehealth provisions short-term for years without settling on permanent legislation, and there is no assurance that outcome changes now, regardless of how many organizations sign a pledge. But the fact that Rocket Doctor has chosen to spend management time and travel resources advocating for a specific legislative outcome that so closely mirrors its own commercial roadmap tells investors something about where leadership believes the company’s future lies. The company is not simply reacting to whatever policy environment exists, but actively working to build the one that aligns with and enables its own mission to access the underserved patient populations it was founded to serve.
Author’s Disclosure: This article reflects the author’s independent analysis and is provided for informational purposes only and should not be considered financial or investment advice. Readers are encouraged to conduct their own independent research and due diligence before making any investment decisions.
